Intertek exhibits at the AAPS National Biotechnology Conference

Meet our large molecule bioanalysis and biopharmaceutical product analysis experts at the 2017 AAPS National Biotechnology Conference, May 1-3, San Diego

Intertek’s experts in bioanalysis of biologics and LC-MS of large and small molecules will be present at Booth 405 to discuss all aspects of contract bioanalytical services. We can help you get your bioanalytical strategy right the first time, to meet both regulatory requirements and challenges presented by complex products, including monoclonal antibodies, ADCs, biosimilars, bispecifics, proteins and diverse biological matrices.

Intertek is also sponsoring the AAPS Foundation’s Mix, Mingle, and Merlot on April 30 at the San Diego Wine & Culinary. This is another great opportunity to meet with our experts to discuss your pharmaceutical and drug development testing needs.

With a focus on providing expert regulatory-driven, analytical and bioanalytical services to support biologic medicines, our laboratories are dedicated to helping clients overcome the challenges of drug development and manufacturing. Over the last 25 years, the Intertek network of Good Laboratory Practice (GLP) and Good Manufacturing Practice (cGMP) laboratories has provided high-quality technical services for some of the world’s largest and most innovative pharmaceutical companies across a range of product types including proteins, monoclonal antibodies, vaccines, PEGylated proteins, antibody drug conjugates, peptides, oligonucleotides and biosimilars.

Learn more about the AAPS NBC
The AAPS NBC is attended by many representatives from biotechnology and pharmaceutical companies, contract research organizations, and multiple regulatory agencies. The conference provides a program that examines both theory and application from multiple perspectives including discovery, development, engineering, and regulatory aspects of the five program themes: bioanalysis and biomarkers; biosimilars; emerging topics, formulation development, drug delivery and manufacturing; and novel therapeutic constructs and modalities including immunotherapies.

 

 
Need help or have a question? +1-858-558-2599
 

Need help or have a question?

+1-858-558-2599
EMEA UK:
+44 161 721 5247